CLINIMIX N14G30E

INF SOL 4X2000ML

SÚKL code 0031985
Name of the product CLINIMIX N14G30E
_MA_MEDICATION_DETAIL_INFO_MED_NAME i CLINIMIX N14G30E
Supplement INF SOL 4X2000ML
Strenght
Pharmaceutical form Solution for infusion
Package 4X2000ML
Route Intravenous use
Language of the pack Czech
Wrap type Bag
Legal status na lékařský předpis
Active substance ALANINE (ALANINUM)
GLYCINE (GLYCINUM)
ARGININE (ARGININUM)
HISTIDINE (HISTIDINUM)
ISOLEUCINE (ISOLEUCINUM)
LEUCINE (LEUCINUM)
LYSINE HYDROCHLORIDE (LYSINI HYDROCHLORIDUM)
MAGNESIUM CHLORIDE HEXAHYDRATE (MAGNESII CHLORIDUM HEXAHYDRICUM)
PHENYLALANINE (PHENYLALANINUM)
SODIUM ACETATE TRIHYDRATE (NATRII ACETAS TRIHYDRICUS)
SODIUM CHLORIDE (NATRII CHLORIDUM)
THREONINE (THREONINUM)
TRYPTOPHAN (TRYPTOPHANUM)
TYROSINE (TYROSINUM)
VALINE (VALINUM)
METHIONINE (METHIONINUM)
DIPOTASSIUM PHOSPHATE (KALII HYDROGENOPHOSPHAS)
PROLINE (PROLINUM)
SERINE (SERINUM)
GLUCOSE MONOHYDRATE (GLUCOSUM MONOHYDRICUM)
CALCIUM CHLORIDE DIHYDRATE (CALCII CHLORIDUM DIHYDRICUM)
ATC group B05BA10
ATC group name ROZTOKY PRO PARENTERÁLNÍ VÝŽIVU, KOMBINACE

Marketing authorisation information

Registration Number 76/ 263/01-C
Type of MA National
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 12. 2018
MA Holder Baxter Healthcare Limited, Thetford
MA Holder country VELKÁ BRITÁNIE
Actual MA holder BAXTER CZECH spol. s r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list